BioSpace News Archive

“I’m a nurse and I thought there should be a way to ensure that operating room floors remain safe and dry,” said an inventor, from Liberty, S.C., “so I invented the (COLLECTION CONVEYOR) CC MAT.”

- “I’m a dentist, and I thought there could be a better way to deal with a runny nose while wearing a mask,” said an inventor from Chicago, Ill.

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway® has released its new hemp-based CBD (cannabidiol) Kannaway® Pure Liquid Flavored Trio.

On Tuesday night, November 20, out of concern for the health of employees and customers, Sobeys Inc. temporarily stopped the sale of all Romaine lettuce products across its national store network until further notice.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has entered into a worldwide OmniAb partnership with iMetabolic Biopharma Corporation (iMBP), an early stage biopharma company located in Tempe, AZ. Under the terms of the partnership, iMBP gains access to the full OmniAb platform including OmniRat®, OmniMouse®, OmniFlic® and OmniChicken™ in their drug discovery efforts.

Cellanyx and clinical collaborators today reported results of a prostate cancer clinical study demonstrating the ability of the company’s live tumor cell phenotypic biomarker test to identify patients with low and intermediate grade prostate cancer at risk of aggressive disease.

Today, Australian-born online store Silky Tots officially launches its U.S platform. Silky Tots make a beautiful range of luxe silk bedding for babies and young children that are not your average sheets and pillow cases

Canon U.S.A., Inc., a leader in digital imaging solutions, and Virtual Imaging, Inc., a wholly owned subsidiary of Canon U.S.A. announce today that they will showcase their lines of radiology offerings at the Radiological Society of North America (RSNA) 104th Scientific Assembly and Annual Meeting at McCormick Place, Chicago, IL, from November 25-30, 2018.

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for quizartinib for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia (AML).

Clarius Mobile Health is pleased to announce a new collective intelligence ultrasound platform at this year’s Radiological Society of North America (RSNA) annual meeting.